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Methods
Routine methods were used to analyze the following: urinary 17-KS (8) , urinary 17-hydroxycorticoids (9), plasma Silber-Porter chromogens (10) , and plasma testosterone (11) . Gas-liquid chromatography. We carried out gas-liquid chromatography (GLC) in a Glowell Chromolab gas chromatograph utilizing a 'Sr ionization detector operating at 1,050 v. The coiled glass columns, 6 feet by i inch i.d., were packed with 2% SE-30 on chromosorb W. Trimethylsilyl derivatives were prepared as noted previously (12) .
Fractionation of urinary steroids. Urinary steroid sulfates and glucuronides were separated by thin layer chromatography in system TN (13) after an etherethanol extraction (14) . Glucuronides and sulfates were hydrolyzed separately either with 8-glucuronidase (Ketodase) or by solvolysis (15) . In the subsequent discussion, steroid sulfates are defined as those steroids having the mobility of steroid monosulfates in TN and hydrolyzed by solvolysis. Glucuronides are defined as those steroids having the mobility of steroid glucuronides in TN and released by j8-glucuronidase. Further steps in purification were chromatography on the silica-alumina column (16) and group fractionation with Girard reagent T and digitonin. For isolation of individual metabolites, the resulting ketonic and nonketonic alpha and beta fractions of differing polarity were then chromatographed in the appropriate systems listed below. Paper Estrogens. The three classical urinary estrogens were isolated from the phenolic fraction as suggested by Engel (18) . Tritiated estrone, estradiol, and estriol 2 were added to the phenolic extract to correct for losses occurring after P-glucuronidase hydrolysis. We separated estriol from estrone and estradiol by partitioning between petroleum -ether-benzene and water. Estrone and estradiol were chromatographed on thin layer silica gel plates in TE, and estriol was chromatographed in 100%o ethyl acetate. All samples were acetylated and chromatographed on thin layer silica gel. Chloroform was used to develop the chromatograms. After saponification, paper chromatography was performed as follows: estrone, Bi; estradiol, Bi; and estriol, C. Subsequent thin layer chromatography of estrone and estradiol in T6 and estriol in T4 was performed. Gas-liquid chromatography of these fractions resulted in single clean peaks for estrone and estriol. Estradiol could-not be identified.
16-Hydroxy DHA. Since this steroid has been found only rarely in urine, its identity was assured by the correspondence of the isolated material with authentic standard3 in paper, thin layer, and gas-liquid chromatography as the free steroid and the acetate. The color changes produced by the Allen reagent and the sulfuric acid spectra were identical for the presumptive and authentic 16-hydroxy DHA. 2 (19) .
Production rates. To measure testosterone production rate, we injected 10.0 ,uc of testosterone-8H in saline intravenously and determined the specific activity of testosterone in urinary testosterone glucuronide (16) . Epitestosterone production rate was estimated similarly after injection of 5 uc of epitestosterone-8H and isolation of epitestosterone from a 3-day urine collection. Blood testosterone production rate was measured by the metabolic clearance technique (20) ; a Bowman infusion pump was used for the constant infusion. It was found subsequently that 26% of the testosterone infused via the venoclysis set was absorbed by the tubing, and appropriate corrections were made. Blood samples were 'H/f'C ratios agreed within 5% during the last three chromatographies, in which the testosterone was measured successively as the acetate, the free alcohol, and androstenedione.
We determined the production rates of DHA and Figure 2 demonstrates the purity of the 16-hydroxy DHA; comparable tracings were obtained for androstenediol and DHA. The mass of androstenediol was measured by GLC only. The coefficient of variation of estimates of mass by GLC averages 7% in our hands. This is the largest error associated with the determination of the specific activities calculated in this paper. Since chemotherapy could not be delayed further, a subsequent control period was not obtained; hence, the decreased excretion of 17-KS after cessation of HCG could conceivably be attributed to the chemotherapy. However, the lack of response of the tumor to the chemotherapeutic regimens that were tried makes this an unlikely possibility.
Urinary 17-hydroxycorticoid excretion averaged 22 mg per day. Since the excretion of pregnanetriols, which are also measured by the method em- ployed, was increased to 6 mg per day, urinary corticoid excretion was actually within the normal range. Plasma Silber-Porter chromogen levels were normal. Testosterone. Total excretion of testosterone ranged between 500 and 1,500 ,ug per day, or some 10 to 30 times normal. These values are not corrected for losses, and the recovery was probably between 40 and 50%. When the sulfates and glucuronides were separated before hydrolysis, the excretion of testosterone isolated from the sulfate fraction was 690 Jng per day.
Plasma testosterone concentration was 1.96 ,g per 100 ml. The metabolic clearance rate of testosterone was 2,700 L per day, about three times the normal clearance rate (21) , indicating extensive extrahepatic clearance of testosterone. As the tumor at autopsy was six times as large as the liver, it was the likely site of the extrahepatic metabolism. Other studies in this patient likewise suggest active participation of the tumor in metabolism of plasma steroids.
The testosterone production rate calculated by the urinary isotope dilution method from the specific activity of urinary testosterone glucuronide was 53 mg per day, or ten times normal. When the blood testosterone production rate was estimated as the product of the metabolic clearance rate and the plasma level (20) , the value was 48 mg per day. The reasonable agreement between these two production rates indicates that the urinary testosterone glucuronide originated almost entirely from the blood testosterone compartment. If a significant fraction of the urinary testosterone glucuronide had been derived from a testosterone compartment other than the plasma testosterone compartment, the production rate estimated by urinary isotope dilution would have been larger than that measured by the metabolic clearance technique (22, 23) .
Origin of plasma testosterone. It could not be established from these data whether the plasma testosterone resulted from "secretion" by the tumor or peripheral production from precursors. The high urinary excretion of DHA sulfate suggested that this conjugate could serve as a precursor of the plasma testosterone. To examine this, we isolated testosterone glucuronide from urine and measured its specific activity after the intravenous infusion of DHA sulfate-8H and DHA-14C (Table I) . It is apparent that the specific activity of testosterone glucuronide was the same as (24) , and since plasma DHA sulfate was the precursor of plasma testosterone in this subject, the production of plasma testosterone could be estimated at 68 mg per day from the production rate of DHA sulfate (Table  II) ( In view of the significance of the sulfoconjugates in steroid biosynthesis (25) and the demonstration that an adrenocortical carcinoma could synthesize testosterone sulfate (26) , it may be reasonably assumed that the testosterone sulfate was synthesized by the tumor. The data of Table II fraction was excreted as the sulfate, although in the case of 16-hydroxy DHA, the glucuronide almost equaled the sulfate. Dehydroepiandrosterone was excreted in amounts similar to those noted in adrenal carcinoma. The urinary levels of pregnenediol, pregnenetriol, and androstenediol were many times the normal values. Similar findings have been described in adrenocortical carcinoma (30) . A high excretion of 16-hydroxy DHA has been described previously in a patient with adrenocortical carcinoma (31) . The origin of the androstenediol sulfate and the 16-hydroxy DHA sulfate was examined by comparing their specific activities to that of DHA sulfate after the infusion of DHA sulfate-3H and DHA-14C (Table IV) . Their specific activities were the same within the limits of error of measurement, which made it likely that the plasma DHA sulfate was the sole precursor of the urinary androstenediol sulfate and 16-hydroxy DHA sulfate. Roberts and associates (32) reported similar findings in a subject with adrenocortical carcinoma.
Excretion of 3a-hydroxysteroids. Urinary androsterone and etiocholanolone levels were greatly elevated, although they totaled only 9% of the DHA sulfate production. These are uncorrected figures, however, and the true excretion may be twice the estimated values. The metabolites of 17-hydroxyprogesterone, pregnanetriol and 17-hydroxypregnanolone, were excreted in increased amounts (Table III) . Pregnanediol excretion was increased proportionately less than the metabolites of other biosynthetic intermediates, suggesting that either progesterone was efficiently utilized by the tumor, or that biosynthesis occurred predominantly via the pathway from 17-hydroxypregnenolone to 17-hydroxyprogesterone, thus bypassing progesterone.
Excretion of il-oxo-steroids. Of considerable interest were the increased urinary titers of the three 11-oxo-17-ketosteroids. The excretion of 6.7 mg per 24 hours of 11-hydroxyandrosterone represented a thirteenfold increase above normal. tince synthesis of this steroid presumably required an 11,8-hydroxylating system in the tumor, the general question of 11,8-hydroxylation was examined. As pregnanetriol excretion was elevated and we could infer 17-hydroxyprogesterone synthesis, we attempted to measure 11-ketopregnanetriol in the urine. However, none was found in this subject's urine, indicating that 11,-hydroxylation of 17-hydroxyprogesterone did not occur to any measurable extent.
To ascertain whether the urinary 17-hydroxycorticoids were metabolites of cortisol produced by the tumor or by the adrenal cortex, we measured tetrahydrocortisol, tetrahydrocortisone, allotetrahydrocortisol, and cortisol together. During a control period, the 24-hour excretion was 7.8 mg; this was decreased to 3.8 mg by the daily administration of 8 mg of dexamethasone. Thus, the titers of cortisol metabolites paralleled adrenocortical function, whereas the excretion of 11-hydroxyandrosterone measured simultaneously was unchanged by dexamethasone. Hence, it seems that the tumor demonstrated some substrate specificity in 11-hydroxylation, a conclusion that has some precedence in a similar study by Savard and associates (33) of a benign interstitial cell tumor.
Tetrahydro substance S was not detected in the urine of this patient. In view of the probable excess of 17-hydroxyprogesterone produced by the tumor, it must be concluded that the tumor did not possess a 21-hydroxylating system and differs in this regard from many adrenocortical tumors.
Estrogens. The excretion of estrone, estradiol, and estriol was measured in four consecutive 24-hour urines. The average excretion of estrone was 75 ,ug per 24 hours; estriol, 29 ,ug per 24 hours; and estradiol, less than 13 ,ug per 24 hours. Other patients with interstitial cell carcinoma have had an increased excretion of estrogens determined either by bioassay (4, 7) or chemically (5) .
The failure to find estradiol may have been due to the relatively small samples used and the large losses before the measurement of estrogen. It cannot be assumed from these high levels that the tumor produced estrogens, since the data are equally compatible with estrogen production peripherally from any of the C10O2 precursors.
Discussion
The rarity of interstitial cell carcinoma has precluded adequate study of its steroid synthetic activity. The 17-KS excretion ranged from 20 to 1,000 mg daily in four reported cases (1, 4, 5, 7) and in our case, and it was thus within the range usually found with adrenocortical carcinoma (34) . Although the steroid biosynthetic activity of the interstitial cell tumor was not suppressed by exogenous androgen as is the normal interstitial cell (35) , the response to HCG demonstrated that the tumor was not completely autonomous. Occasional adrenocortical carcinomas have similarly shown ACTH responsiveness, but there has been a uniform inability to suppress their steroid output with exogenous corticoids (34) .
This patient and the patient described by Abelson and co-workers (7) had a high plasma concentration of testosterone, the characteristic secretory product of the Leydig cell. Since this patient's remaining testis was atrophic, it seems unlikely that it could have accounted for a significant fraction of the plasma testosterone.
In spite of a high metabolic clearance rate of testosterone, the plasma level was maintained at 1.96 jug per 100 ml, due to a high testosterone blood production rate. An unexpected conclusion was that almost all of this testosterone had its origin from plasma DHA sulfate, and the close agreement between the specific -activities of tritium and carbon in urinary DHA sulfate and in urinary testosterone glucuronide left no alternative. This conclusion was strengthened by the estimate of testosterone production obtained from the independent measurement of DHA sulfate production and its conversion to testosterone glucuronide. This emphasizes the hazards of assuming synthesis of a steroid by a tumor when such a steroid can be synthesized peripherally from other steroid precursors.
The agreement between the two methods of estimating testosterone production rates is of considerable interest in view of prior studies demonstrating that, in general, only a small moiety of plasma testosterone is due to hepatic testosterone synthesis from other precursors (23, 35, 36) . This phenomenon most probably reflects rapid conjugation of the newly synthesized testosterone. This has not been invariable, however, and in one patient it was shown that all of the testosterone synthesized peripherally from androstenedione appeared in the plasma as free testosterone (23) . Thus, variability in rates of conversion to glucuronide of testosterone synthesized in the liver could have a decisive role in determining plasma testosterone levels. Had the production rates not been measured by both techniques, it would have been concluded that plasma DHA sulfate could not have been the source of plasma testosterone.
The measurement of urinary metabolites of known intermediates of biosynthetic sequences permits an informed guess about in vivo synthetic activity. Thus, the excretion of large amounts of pregnenediol, pregnenetriol, androstenediol, and DHA reflected the production of proportionately increased amounts of their respective precursors, pregnenolone, 17-hydroxypregnenolone, and DHA. A subsequent inference is that tumor 3,8-hydroxysteroid dehydrogenase activity was limited, since these steroids were not converted to the corresponding &4-3-ketosteroids. This pattern, too, is characteristic of adrenocortical carcinoma (37) .
The excretion of individual 11-oxo-17-ketosteroids was measured by Abelson and associates (7) , and the excretion of each was increased. The findings in our case are similar, but the largest increase was in the excretion of 11-hydroxyandrosterone. This steroid is the principal metabolite of 11,8-hydroxyandrostenedione (38) . Since suppression of the adrenal cortex did not decrease the excretion of 11-hydroxyandrosterone, we have concluded that 11,8-hydroxyandrostenedione was synthesized by the tumor.
In three cases of benign interstitial cell tumor (33, 39, 40) 11-hydroxyandrosterone was also excreted in increased amounts. Savard and associates (33) suggested that the 11/3-hydroxylating system showed substrate specificity, since they were unable to demonstrate 11,8-hydroxylation of progesterone. Our findings support this suggestion, since we were unable to find 11-ketopregnanetriol in spite of an abundant supply of the substrates for 11ft-hydroxylation, 17- The resemblance of this tumor to adrenocortical carcinoma in its functional aspect is striking. The high production rate of DHA sulfate and the excretion of greatly increased amounts of DHA and other A5 steroids are in the usual pattern of functional adrenal carcinoma (37) . Many adrenal carcinomas likewise demonstrate a decreased activity of 3/3-hydroxysteroid dehydrogenase and, in some, this enzyme appears to be absent. The occurrence of 11,8-hydroxylation of androstenedione and the simultaneous lack of 1 1,8-hydroxylation of C-21 pregnane derivatives have also been described in adrenocortical carcinoma (37) . The interstitial cell carcinoma synthesized small amounts, if any, of testosterone, the important secretory product of the interstitial cell; similarily, some adrenal cancers that synthesize several corticoids fail to synthesize the characteristic adrenal cortical secretory product, cortisol.
A singular point of difference between the two cancers is the development of an 11,8-hydroxylating system in the interstitial cell carcinoma. As far as we are aware, 11,3-hydroxylation has not been shown to occur in any normal mammalian testis. Thus, this interstitial cell cancer is an exception to the generalization that the development of neoplasia is not accompanied by the appearance of new enzymes. Rather, the activity of normal enzyme systems may be greatly reduced or disappear, as so often happens to 11,8-hydroxylation in adrenocortical carcinoma. These comparisons rest on the unequivocal identification of the tumor in this case as an interstitial cell carcinoma. This question will be considered in detail by Horner and Evans (41) , but it should be stated that there was no disagreement among experienced pathologists regarding the origin of the cancer. One could, however, make a convincing argument that biochemical and morphologic criteria have equal validity.
Summary
Steroid studies in a patient with metastatic interstitial cell carcinoma have been described. The patient excreted large amounts of 17-ketosteroids, comprising both the li-deoxy-and the l1-oxysteroids. The tumor responded to human chorionic gonadotropin but was not suppressed by exogenous androgen.
The plasma testosterone level was four times normal, and it was demonstrated that plasma dehydroepiandrosterone sulfate was the source of the plasma testosterone. The dehydroepiandrosterone sulfate production rate was 2,270 mg per day. Evidence was presented that the tumor secreted testosterone sulfate as well.
The excretion of metabolites of the biosynthetic precursors of testosterone demonstrated that there was a low activity of tumor 3,8-hydroxysteroid de- hydrogenase. The steroid synthetic activity of this cancer resembled closely that of adrenocortical cancer.
